The influence of catalyst in reaction 73590-85-9

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)Name: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

Most of the natural products isolated at present are heterocyclic compounds, so heterocyclic compounds occupy an important position in the research of organic chemistry. A compound: 73590-85-9, is researched, SMILESS is CC1=CN=C(CSC2=NC3=CC(OC)=CC=C3N2)C(C)=C1OC, Molecular C17H19N3O2SJournal, Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences called A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP-HPLC after a simple liquid-liquid extraction procedure. [Erratum to document cited in CA146:074538], Author is Rezk, Naser L.; Brown, Kevin C.; Kashuba, Angela D. M., the main research direction is erratum omeprazole metabolite determination blood HPLC.Name: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole.

On page 317, Table 2 is incorrect; in the first column titled “”Analyte””, the entries “”omeprazole sulfone”” and “”omeprazole”” should be reversed. On page 319, Table 3 is incorrect for the same reason Table 2 is incorrect. On pages 318 and 320, Figs. 3-5 are incorrect; each of the “”OPZ-SFN”” peaks should be labeled “”OPZ”” and the “”OPZ”” peaks should be labeled “”OPZ-SFN.””. On page 320, the legend of Figure 6 is incorrect; “”omeprazole sulfone”” should be replaced with “”omeprazole”” and “”omeprazole”” should be replaced with “”omeprazole sulfone.””.

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)Name: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

New explortion of 56621-48-8

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Recommanded Product: 4-(Piperazin-1-yl)phenol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Recommanded Product: 4-(Piperazin-1-yl)phenol. So far, in addition to halogen atoms, other non-metallic atoms can become part of the aromatic heterocycle, and the target ring system is still aromatic. Compound: 4-(Piperazin-1-yl)phenol, is researched, Molecular C10H14N2O, CAS is 56621-48-8, about Divergent Pathways for Reactions of 3-Formylchromone with Cyclic Secondary Amines in Alcoholic Media.

Reaction of 3-formylchromone with cyclic secondary amines in methanol results in (E)-chromanones I [X = CH, R = Ph; X = O, R = none; X = N, R = 4-MeC6H4, 2,6-Me2C6H3, 2-MeOC6H4, etc.] and II, while use of ethanol leads to (E)-bis(morpholino)chromanone III or enaminoketones as dihydropyran ring-opening products. The solubility of the formed products in alc. media is postulated to be a key factor that determines the reaction pathway.

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Recommanded Product: 4-(Piperazin-1-yl)phenol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Discovery of 73590-85-9

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)COA of Formula: C17H19N3O2S, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

The three-dimensional configuration of the ester heterocycle is basically the same as that of the carbocycle. Compound: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole(SMILESS: CC1=CN=C(CSC2=NC3=CC(OC)=CC=C3N2)C(C)=C1OC,cas:73590-85-9) is researched.HPLC of Formula: 591-12-8. The article 《Regioselective C-H hydroxylation of omeprazole sulfide by Bacillus megaterium CYP102A1 to produce a human metabolite》 in relation to this compound, is published in Biotechnology Letters. Let’s take a look at the latest research on this compound (cas:73590-85-9).

Objectives: To find a simple enzymic strategy for the efficient synthesis of the expensive 5′-hydroxyomeprazole sulfide, a recently identified minor human metabolite, from omeprazole sulfide, which is an inexpensive substrate. Results: The practical synthetic strategy for the 5′-OH omeprazole sulfide was accomplished with a set of highly active CYP102A1 mutants, which were obtained by blue colony screening from CYP102A1 libraries with a high conversion yield. The mutant and even the wild-type enzyme of CYP102A1 catalyzed the high regioselective (98 %) C-H hydroxylation of omeprazole sulfide to 5′-OH omeprazole sulfide with a high conversion yield (85-90 %). Conclusions: A highly efficient synthesis of 5′-OH omeprazole sulfide was developed using CYP102A1 from Bacillus megaterium as a biocatalyst.

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)COA of Formula: C17H19N3O2S, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Chemical Properties and Facts of 56621-48-8

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Name: 4-(Piperazin-1-yl)phenol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov’t, Journal of Medicinal Chemistry called Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors, Author is Pace, Jennifer R.; Teske, Kelly A.; Chau, Lianne Q.; Dash, Radha Charan; Zaino, Angela M.; Wechsler-Reya, Robert J.; Hadden, M. Kyle, which mentions a compound: 56621-48-8, SMILESS is OC1=CC=C(N2CCNCC2)C=C1, Molecular C10H14N2O, Name: 4-(Piperazin-1-yl)phenol.

The Food and Drug Administration-approved antifungal agent, itraconazole (ITZ), has been increasingly studied for its novel biol. properties. In particular, ITZ inhibits the hedgehog (Hh) signaling pathway and has the potential to serve as an anticancer chemotherapeutic against several Hh-dependent malignancies. We have extended our studies on ITZ analogs as Hh pathway inhibitors through the design, synthesis, and evaluation of novel des-triazole ITZ analogs that incorporate modifications to the triazolone/side chain region of the scaffold. Our overall results suggest that the triazolone/side chain region can be replaced with various functionalities (hydrazine carboxamides and meta-substituted amides) resulting in improved potency when compared to ITZ. Our studies also indicate that the stereochem. orientation of the dioxolane ring is important for both potent Hh pathway inhibition and compound stability. Finally, our studies suggest that the ITZ scaffold can be successfully modified in terms of functionality and stereochem. to further improve its anti-Hh potency and physicochem. properties.

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Name: 4-(Piperazin-1-yl)phenol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Archives for Chemistry Experiments of 56621-48-8

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Application In Synthesis of 4-(Piperazin-1-yl)phenol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Most of the compounds have physiologically active properties, and their biological properties are often attributed to the heteroatoms contained in their molecules, and most of these heteroatoms also appear in cyclic structures. A Journal, Article, ACS Medicinal Chemistry Letters called Affinity-Based Selectivity Profiling of an In-Class Selective Competitive Inhibitor of Acyl Protein Thioesterase 2, Author is Won, Sang Joon; Eschweiler, Joseph D.; Majmudar, Jaimeen D.; Chong, Fei San; Hwang, Sin Ye; Ruotolo, Brandon T.; Martin, Brent R., which mentions a compound: 56621-48-8, SMILESS is OC1=CC=C(N2CCNCC2)C=C1, Molecular C10H14N2O, Application In Synthesis of 4-(Piperazin-1-yl)phenol.

Activity-based protein profiling (ABPP) has revolutionized the discovery and optimization of active-site ligands across distinct enzyme families, providing a robust platform for in-class selectivity profiling. Nonetheless, this approach is less straightforward for profiling reversible inhibitors and does not access proteins outside the ABPP probe’s target profile. While the active-site competitive acyl protein thioesterase 2 (APT2) inhibitor ML349 (Ki = 120 nM) is highly selective within the serine hydrolase enzyme family, it could still interact with other cellular targets. Here we present a chemoproteomic workflow to enrich and profile candidate ML349-binding proteins. In human cell lysates, biotinylated-ML349 enriches a recurring set of proteins, including metabolite kinases and flavin-dependent oxidoreductases that are potentially enhanced by avidity-driven multimeric interactions. Confirmatory assays by native mass spectrometry and fluorescence polarization quickly rank-ordered weak off-targets, providing justification to explore ligand interactions and stoichiometry beyond ABPP.

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Application In Synthesis of 4-(Piperazin-1-yl)phenol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Chemistry Milestones Of 56621-48-8

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Related Products of 56621-48-8, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 4-(Piperazin-1-yl)phenol, is researched, Molecular C10H14N2O, CAS is 56621-48-8, about Different strategies in electrochemical synthesis of new mono and di-substituted hydroquinone and benzoquinone, the main research direction is strategy electrochem synthesis mono di hydroquinone benzoquinone derivative.Related Products of 56621-48-8.

Electrochem. syntheses of 2-indolyl-5-arylsulfonyl-p-benzoquinone derivatives were carried out in two successive oxidation steps. The 1st involves the oxidation of hydroquinone, 4-(piperazin-1-yl)-phenol and 1-(4-(4-hydroxyphenyl)-piperazin-1-yl) ethanone in the presence of arylsulfinic acids as nucleophiles. The authors’ voltammetric data indicate that electrochem. generated p-benzoquinone participates in Michael addition reaction with arylsulfinic acids leading to the 2-(arylsulfonyl) benzene-1,4-diols. The 2nd consists of the oxidation of 2-(arylsulfonyl) benzene-1,4-diols in the presence of 1,2-dimethylindole and the formation of 2-indolyl-5-arylsulfonyl-p-benzoquinone derivatives as the final products. A plausible mechanism for the synthesis of 2-indolyl-5-arylsulfonyl-p-benzoquinone derivatives is also presented.

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Related Products of 56621-48-8, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Chemical Research in 56621-48-8

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Recommanded Product: 4-(Piperazin-1-yl)phenol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Recommanded Product: 4-(Piperazin-1-yl)phenol. The reaction of aromatic heterocyclic molecules with protons is called protonation. Aromatic heterocycles are more basic than benzene due to the participation of heteroatoms. Compound: 4-(Piperazin-1-yl)phenol, is researched, Molecular C10H14N2O, CAS is 56621-48-8, about Targeting DNA Repair in Tumor Cells via Inhibition of ERCC1-XPF. Author is Elmenoufy, Ahmed H.; Gentile, Francesco; Jay, David; Karimi-Busheri, Feridoun; Yang, Xiaoyan; Soueidan, Olivier M.; Weilbeer, Claudia; Mani, Rajam S.; Barakat, Khaled H.; Tuszynski, Jack A.; Weinfeld, Michael; West, Frederick G..

The ERCC1-XPF heterodimer is a 5′-3′ structure-specific endonuclease, which plays an essential role in several DNA repair pathways in mammalian cells. ERCC1-XPF is primarily involved in the repair of chem. induced helix-distorting and bulky DNA lesions, such as cyclobutane pyrimidine dimers (CPDs), and DNA interstrand cross-links. Inhibition of ERCC1-XPF has been shown to potentiate cytotoxicity of platinum-based drugs and cyclophosphamide in cancer cells. In this study, the previously described ERCC1-XPF inhibitor 4-((6-chloro-2-methoxyacridin-9-yl)amino)-2-((4-methylpiperazin-1-yl)methyl)phenol (compound 1) was used as a reference compound Following the outcome of docking-based virtual screening (VS), we synthesized seven novel derivatives of 1 that were identified in silico as being likely to have high binding affinity for the ERCC1-XPF heterodimerization interface by interacting with the XPF double helix-hairpin-helix (HhH2) domain. Two of the new compounds, 4-((6-chloro-2-methoxyacridin-9-yl)amino)-2-((4-cyclohexylpiperazin-1-yl)methyl)phenol (compound 3) and 4-((6-chloro-2-methoxyacridin-9-yl)amino)-2-((4-(2-(dimethylamino)ethyl) piperazin-1-yl) methyl) phenol (compound 4), were shown to be potent inhibitors of ERCC1-XPF activity in vitro. Compound 4 showed significant inhibition of the removal of CPDs in UV-irradiated cells and the capacity to sensitize colorectal cancer cells to UV radiation and cyclophosphamide.

If you want to learn more about this compound(4-(Piperazin-1-yl)phenol)Recommanded Product: 4-(Piperazin-1-yl)phenol, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(56621-48-8).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Brief introduction of 73590-85-9

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)COA of Formula: C17H19N3O2S, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

The chemical properties of alicyclic heterocycles are similar to those of the corresponding chain compounds. Compound: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole, is researched, Molecular C17H19N3O2S, CAS is 73590-85-9, about Investigating the presence of omeprazole in waters by liquid chromatography coupled to low and high resolution mass spectrometry: degradation experiments, the main research direction is omeprazole water liquid chromatog mass spectrometry degradation; omeprazole; surface water; time-of-flight mass spectrometry; transformation/degradation products; triple quadrupole mass spectrometry; ultra-high-performance liquid chromatography; urban wastewater.COA of Formula: C17H19N3O2S.

Omeprazole is one of the most consumed pharmaceuticals around the world. However, this compound is scarcely detected in urban wastewater and surface water. The absence of this pharmaceutical in the aquatic ecosystem might be due to its degradation in wastewater treatment plants, as well as in receiving water. Different laboratory-controlled degradation experiments were carried out on surface water to elucidate omeprazole transformation products (TPs). Surface water spiked with omeprazole was subjected to hydrolysis, photo-degradation under both sunlight and UV radiation and chlorination. Analyses by liquid chromatog. coupled to quadrupole time-of-flight mass spectrometry (LC-QTOF MS) permitted identification of ≤17 omeprazole TPs. In a subsequent step, the TPs identified were sought in surface water and urban wastewater by LC-QTOF MS and by LC coupled to tandem mass spectrometry with triple quadrupole. The parent omeprazole was not detected in any of the samples, but 4 TPs were found in several water samples. The most frequently detected compound was OTP 5 (omeprazole sulfide), which might be a reasonable candidate to be included in monitoring programs rather than the parent omeprazole. Copyright pr 2013 John Wiley & Sons, Ltd.

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)COA of Formula: C17H19N3O2S, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

New learning discoveries about 73590-85-9

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)Quality Control of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

In organic chemistry, atoms other than carbon and hydrogen are generally referred to as heteroatoms. The most common heteroatoms are nitrogen, oxygen and sulfur. Now I present to you an article called Pharmacokinetics of [14C]omeprazole in patients with impaired renal function., published in 1986, which mentions a compound: 73590-85-9, mainly applied to , Quality Control of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole.

Pharmacokinetics of [14C]omeprazole and its metabolites were studied after single intravenous and oral doses of 20 and 40 mg, respectively, to 12 patients with chronic renal insufficiency. Blood samples for determination of total radioactivity, omeprazole, OH-omeprazole, sulfone, and sulfide were taken for 24 hours. Urine was collected over 96 hours for determination of total radioactivity and during the first 24 hours for additional assay of omeprazole and metabolites. The mean systemic availability was 70%. The mean plasma t1/2 of omeprazole was 0.6 hours. Unchanged omeprazole was not measurable in urine. Derived pharmacokinetic constants of intact omeprazole were within the range of those reported in healthy individuals. The accumulated 24-hour excretion of radioactive metabolites was related significantly to creatinine clearance. The cumulative excretion of total radioactivity in urine over 96 hours in percent of given dose varied between 25% and 83%.

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)Quality Control of 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Brief introduction of 73590-85-9

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)Name: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

In general, if the atoms that make up the ring contain heteroatoms, such rings become heterocycles, and organic compounds containing heterocycles are called heterocyclic compounds. An article called Regioselective C-H hydroxylation of omeprazole sulfide by Bacillus megaterium CYP102A1 to produce a human metabolite, published in 2017-01-31, which mentions a compound: 73590-85-9, Name is 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole, Molecular C17H19N3O2S, Name: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole.

Objectives: To find a simple enzymic strategy for the efficient synthesis of the expensive 5′-hydroxyomeprazole sulfide, a recently identified minor human metabolite, from omeprazole sulfide, which is an inexpensive substrate. Results: The practical synthetic strategy for the 5′-OH omeprazole sulfide was accomplished with a set of highly active CYP102A1 mutants, which were obtained by blue colony screening from CYP102A1 libraries with a high conversion yield. The mutant and even the wild-type enzyme of CYP102A1 catalyzed the high regioselective (98 %) C-H hydroxylation of omeprazole sulfide to 5′-OH omeprazole sulfide with a high conversion yield (85-90 %). Conclusions: A highly efficient synthesis of 5′-OH omeprazole sulfide was developed using CYP102A1 from Bacillus megaterium as a biocatalyst.

If you want to learn more about this compound(5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole)Name: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]thio]benzimidazole, you may wish to communicate with the author of the article,or consult the relevant literature related to this compound(73590-85-9).

Reference:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem